ChatAbout Dr. Sudha Sinha
- Dr. Sudha Sinha is an oncologist with over 13 of experience. She is also a renowned hematologist.
- She has special interest in women related cancers such as Breast Cancer and Gestational trophoblastic diseases.
- She worked on the expression and purification of erythrocyte macrophage protein and development of Anti-EMP antibodies.
- She worked on the development of cystein protease inhibitors as anti-malarial Drugs, and on the investigation of molecular mechanisms by which erythroblast-macrophage interactions promote erythroid maturation.
- She established the department of medical oncology, 60-bed adult leukemia program and 80 pediatric oncology programs.
- Dr. Sudha Sinha is a member of European Society of Medical Oncology and Indian Medical Association.
- After completing her MBBS from Gandhi Medical College, University of Health Sciences; Hyderabad (1996), she was Intern in Internal medicine at St. Barnabas medical center Livingston, NJ. USA from 1998 -1999. She was also Resident in internal medicine at Barnabas Medical Center Livingston, NJ. USA (1999- 2001).
- Dr. Sinha held the post of Assistant Professor at MNJ Institute of oncology and regional cancer center, Hyderabad She also started The ICMR ( Indian Council of Medical Research) funded hospital based national cancer registry program.
Hospital
LocationSpecial Interest
• Hematologist and oncologist • Breast Cancer, Gynecological Cancers • Gestational Trophoblastic Diseases
List Of Treatments
- Metastatic Tumors Treatment
- Chemotherapy
- Radiotherapy
- Adrenal Cancer Treatment
- Anal Cancer Treatment
- Bile Duct Cancer Treatment
- Bladder Cancer Treatment
- Bone Cancer Treatment
- Breast Cancer-Surgical
- Cancer in Children
- Carcinoma of Unknown Primary (CUP) Treatment
- Castleman Disease Treatment
- Cervical Cancer Treatment
- Endometrial Cancer Treatment
- Esophagus Cancer Treatment
- Ewing Family of Tumors Treatment
- Eye Cancer Treatment
- Gallbladder Cancer Treatment
- Carcinoid Tumors Treatment
- Gastrointestinal Stromal Tumor GIST Treatment
- Gestational Trophoblastic Disease (GTD) Treatment
- Hodgkin Disease Treatment
- Kaposi Sarcoma Treatment
- Kidney Cancer Treatment
- Laryngeal and Hypopharyngeal Cancer Treatment
- Acute Lymphocytic Leukemia - ALL in Adults
- Leukemia in Children
- Liver Cancer
- Lung Cancer Treatment
- Non-Small Cell Lung Cancer (NSCLC) Treatment
- Small-cell Carcinoma Treatment
- Lung Carcinoid Tumor Treatment
- Skin Lymphoma Treatment
- Malignant Mesothelioma Treatment
- Nasal Cavity and Paranasal Sinus Cancer Treatment
- Nasopharyngeal Cancer Treatment
- Neuroblastoma
- Non-Hodgkin Lymphoma (NHL) Treatment
- Non-Hodgkin Lymphoma In Children
- Oral Cavity and Oropharyngeal Cancer
- Osteosarcoma (OS) Treatment
- Ovarian Cancer Surgery
- Pancreatic Cancer
- Penile Cancer Treatment
- Prostate Cancer-Surgical
- Retinoblastoma (RB) Treatment
- Rhabdomyosarcoma (RMS) Treatment
- Salivary Gland Cancer
- Soft Tissue Sarcoma Treatment
- Skin Cancer
- Basal Cell and Squamous Cell Carcinoma
- Skin Cancer - Melanoma
- Small Intestine Cancer Treatment
- Stomach Cancer Treatment
- Testicular Cancer Treatment
- Thymoma and Thymic Carcinoma Treatment
- Thyroid Cancer Treatment
- Uterine Sarcoma
- Vaginal Cancer Treatment
- Vulvar Cancer Treatment
- Waldenstrom Macroglobulinemia
- Wilms Tumor (Nephroblastoma)
- Breast Biopsy
- Pediatric Bone Marrow Transplant
- Oral Cancer - Surgical
- Breast Cancer
- Leukemia Treatment
- Hairy Cell Leukemia - HCL
- Fallopian Tube Cancer
- Ovarian Germ Cell Tumor
- Ovarian Primary Peritoneal Cancer
- Medullary Carcinoma
- Papillary Thyroid Cancer Treatment
- Bone Marrow Cancer
- Ovarian Sex Cord Stromal Tumor
- Invasive Lobular Carcinoma
- Colon Cancer Treatment
- Cancer Treatment
- Adenocarcinoma - Glandular Cancer Treatment
- Immunotherapy
- Transarterial Chemoembolization - TACE
- Breast Conservation Surgery - BCS
- Breast Lumpectomy
- IMRT
- HIPEC
- Parathyroidectomy
- Lobectomy
- Completion Thyroidectomy
Work Experience of Dr. Sudha Sinha
Senior Consultant, American Oncology Institute, Hyderabad
Senior Consultant, Continental Hospitals, Hyderabad
, Assistant Professor, MNJ Institute of Oncology and Regional Cancer Center, Hyderabad
Dr. Sudha Sinha's
- Fellowship, 2005, Caritas St. Elizabeth’s Medical Center, Tufts University School of Medicine, Boston, MA. USA
- Fellowship, 2005, Caritas St. Elizabeth’s Medical Center Tufts University School of Medicine Boston, MA. USA
- , 2001, Barnabas Medical Center Livingston, NJ. USA
- , 1999, St. Barnabas Medical Center Livingston, NJ. USA
- MBBS, 1996, Gandhi Medical College, University of Health Sciences, Hyderabad
• Member of European Society of Medical Oncology • Member of Indian Medical Association.
- Cingeetham A, Vuree S, Dunna NR, Gorre M, Nanchari SR, Edathara PM, Meka P, Annamaneni S, Digumarthi R, Sinha S, Satti V. Tumour Biol. 2015 May 10. Influence Of BCL2-938C >A And BAX-248G>A Promoter Polymorphisms In the Development of AML: Case-control study from south India
- Cingeetham A1, Vuree S, Jiwatani S, Kagita S, Dunna NR, Meka PB, Gorre M, Annamaneni S, Digumarti R, Sinha S, Satti V. Asian Pac J Cancer Prev. 2015;16(7):2707-12. Role of The MDM2 Promoter Polymorphism (-309T>G) In Acute Myeloid Leukemia Development
- Digumarti R, Sinha S, Nirni SS, Patil SG, Pedapenki RM. Indian J Cancer. 2014 51(2):180-3. Efficacy of Rasburicase (Recombinant Urate Oxidase) in the prevention and treatment of Malignancy-Associated Hyperuricemia: An Indian Experience.
- Chiranjeevi P, Spurthi KM, Rani NS, Kumar GR, Aiyengar TM, Saraswati M, Srilatha G, Kumar GK, Sinha S, Kumari CS, Reddy BN, Vishnupriya S, Rani HS. Tumour Biol. 2013 Dec 20. [Epub Ahead of Print]. Gelatinase B (- 1562C/T) Polymorphism In Tumor Progression And Invasion of Breast Cancer.
- Attili SV, Ananda B, Mandapal T, Anjaneyulu V, Sinha S, Reddy OC. Gastrointest Cancer Res. 2011 Sep;4(5-6):173-7.Factors influencing progression- free survival in gastrointestinal stromal tumors with special reference to pathologic features, cytogenetics and radiologic response.
- Suresh AV, Varma PP, Sinha S, Deepika S, Raman R, Srinivasan M, Mandapal T, Reddy CO, Anand BB. J Cancer Res Ther. 2010 Oct- Dec;6(4):448-51.Risk-Scoring System For Predicting Mucositis In Patients of Head And Neck Cancer Receiving Concurrent Chemoradiotherapy .
- Chirivella S, Rajappa S, Sinha S, Eden T, Barr RD. Indian J Pediatr. 2009 Dec;76(12):1231-Health-Related Quality of Life Among Children With Cancer In Hyderabad, India.
- Bala S, Kumar A, Soni S, Sinha S, Hanspal M.Biochem Biophys Res Commun. 2006 Apr 21; 342(4):1040-8. Emp Is A Component of The Nuclear Matrix of Mammalian Cells And Undergoes Dynamic Rearrangements During Cell Division.
- Sinha S, Poh KK, Sodano D, Flanagan J, Ouilette C, Kearney M, Heyd L, Wollins J, Losordo D, Weinstein R.J Clin Apher. 2006 Jul;21(2):116-20.Safety And Efficacy of Peripheral Blood Progenitor Cell Mobilization And Collection In Patients With Advanced Coronary Heart Disease.
Wondering where to start?
(Get Free opinion, Quote, Medical Visa Invitation and Assistance at every step of your treatment.)
Doctor Similar to Dr. Sudha Sinha in Hyderabad
Dr. S.V.S.S Prasad
Medical Oncologist
Consultant
DM,MBBS,MD
Hyderabad, India
39 years of experience
Apollo Hospitals, Jubilee Hills Hyderabad
Dr. Srinivas Chakravarthy Gummaraju
Medical Oncologist
Director
Fellowship,MBBS,MD
Hyderabad, India
19 years of experience
Apollo Hospitals, Jubilee Hills Hyderabad
Dr. Vijay Anand Reddy
Medical Oncologist
Director
DNB,Fellowship,MD
Hyderabad, India
30 years of experience
Apollo Hospitals, Jubilee Hills Hyderabad
Dr. A. V. S. Suresh
Medical Oncologist
Consultant
DM,MBBS,MD
Hyderabad, India
12 years of experience
Continental Hospitals, Hyderabad
Dr. Sainath Bhethanabhotla
Medical Oncologist
Consultant
DM,MBBS,MD
Hyderabad, India
10 years of experience
Star Hospital, Financial District
Dr. Ravi Kumar
Medical Oncologist
Consultant
DNB,MBBS
Hyderabad, India
12 years of experience
Gleneagles Global Hospital, Lakdikapul, Hyderabad
Dr Saadvik Raghuram
Medical Oncologist
Consultant
DM,MBBS,MD
Hyderabad, India
7 years of experience
Medicover Hospital, Hitec City
Dr. Harish Kancharla
Medical Oncologist
Consultant
DM,MBBS,MD
Hyderabad, India
9 years of experience
